LAMP
DEAD

Serial Number

88787581

Owner

CytoDyn Inc.

Attorney

Jared M. Barrett

Filing Date

Feb 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LAMP Trademark

Serial Number: 88787581

LAMP is a trademark filed by CytoDyn Inc. on February 6, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CytoDyn Inc. (14 trademarks)

1111 Main Street, Suite 660
Vancouver, WA 98660

Entity Type: 03

Trademark Details

Filing Date

February 6, 2020

Registration Date

Not Registered

Published for Opposition

November 3, 2020

Goods & Services

therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research and medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 30, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 29, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 29, 2022 EXRA
SOU EXTENSION 3 GRANTED
Oct 27, 2022 EX3G
SOU EXTENSION 3 FILED
Oct 27, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 27, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2022 EXRA
SOU EXTENSION 2 GRANTED
Apr 27, 2022 EX2G
SOU EXTENSION 2 FILED
Apr 27, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 27, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2021 EXRA
SOU EXTENSION 1 GRANTED
Oct 25, 2021 EX1G
SOU EXTENSION 1 FILED
Oct 25, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 25, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 27, 2021 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 14, 2021 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 1, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Nov 3, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2020 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2020 NWOS
NEW APPLICATION ENTERED
Feb 10, 2020 NWAP